Co-carcinogenic effect of progesterone on 20-methylcholanthrene induced cervical carcinoma in mice.
D000818:Animals; D002277:Carcinoma / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000473:pathology; D003692:Delayed-Action Preparations; D004357:Drug Synergism; D005260:Female; D007279:Injections, Subcutaneous; D008748:Methylcholanthrene; D051379:Mice; D008810:Mice, Inbred C57BL; D009093:Mucus / Q000378:metabolism; D011374:Progesterone / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced* / Q000473:pathology
D003692:Delayed-Action Preparations; D011374:Progesterone; D008748:Methylcholanthrene